Literature DB >> 23525354

Neuropsychiatric Symptoms in Inborn Errors of Metabolism: Incorporation of Genomic and Metabolomic Analysis into Therapeutics and Prevention.

Lisa Pan1, Jerry Vockley.   

Abstract

Inborn errors of metabolism may present as a spectrum ranging from neonatal lethality to non-specific symptoms. Neuropsychiatric manifestations have been identified in three groups: those presenting as emergencies, those with chronic fluctuating symptoms, and those associated with mental retardation. Milder central nervous system specific inborn errors of metabolism may also present later in life with isolated psychiatric symptoms. Inborn errors of metabolism presenting with neuropsychiatric symptoms are described with illustrative case examples. Metabolomic and genomic approaches to identification and treatment are described.

Entities:  

Keywords:  CNS-specific; depression; genomics; inborn error of metabolism; metabolomics; neuropsychiatric; psychosis; suicide

Year:  2013        PMID: 23525354      PMCID: PMC3603703          DOI: 10.1007/s40142-012-0004-0

Source DB:  PubMed          Journal:  Curr Genet Med Rep        ISSN: 2167-4876


  34 in total

1.  Erratum: GTP-cyclohydrolase deficiency responsive to sapropterin and 5-HTP supplementation: relief of treatment-refractory depression and suicidal behaviour.

Authors:  Lisa Pan; Brian William McKain; Suneeta Madan-Khetarpal; Marianne McGuire; Rasim S Diler; James M Perel; Jerry Vockley; David A Brent
Journal:  BMJ Case Rep       Date:  2011-06-30

Review 2.  Adult phenylketonuria outcome and management.

Authors:  F Trefz; F Maillot; K Motzfeldt; M Schwarz
Journal:  Mol Genet Metab       Date:  2011-08-26       Impact factor: 4.797

3.  Neurocognitive profile in a case of maple syrup urine disease.

Authors:  Karin S Walsh; Megan N Scott
Journal:  Clin Neuropsychol       Date:  2010-03-02       Impact factor: 3.535

4.  Homocysteine, folate, methylation, and monoamine metabolism in depression.

Authors:  T Bottiglieri; M Laundy; R Crellin; B K Toone; M W Carney; E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

5.  Screening for cognitive and social-emotional problems in individuals with PKU: tools for use in the metabolic clinic.

Authors:  S Waisbren; D A White
Journal:  Mol Genet Metab       Date:  2010       Impact factor: 4.797

6.  Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness.

Authors:  M H Abbott; S E Folstein; H Abbey; R E Pyeritz
Journal:  Am J Med Genet       Date:  1987-04

7.  Folate deficiency, biopterin and monoamine metabolism in depression.

Authors:  T Bottiglieri; K Hyland; M Laundy; P Godfrey; M W Carney; B K Toone; E H Reynolds
Journal:  Psychol Med       Date:  1992-11       Impact factor: 7.723

8.  Acute postpartum mental status change and coma caused by previously undiagnosed ornithine transcarbamylase deficiency.

Authors:  Dirk E Peterson
Journal:  Obstet Gynecol       Date:  2003-11       Impact factor: 7.661

Review 9.  Metabolism as a complex genetic trait, a systems biology approach: implications for inborn errors of metabolism and clinical diseases.

Authors:  Jerry Vockley
Journal:  J Inherit Metab Dis       Date:  2008-10-05       Impact factor: 4.982

Review 10.  Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults.

Authors:  F Sedel; N Baumann; J-C Turpin; O Lyon-Caen; J-M Saudubray; D Cohen
Journal:  J Inherit Metab Dis       Date:  2007-08-10       Impact factor: 4.982

View more
  2 in total

1.  Prophylactic ketamine alters nucleotide and neurotransmitter metabolism in brain and plasma following stress.

Authors:  Josephine C McGowan; Collin Hill; Alessia Mastrodonato; Christina T LaGamma; Alexander Kitayev; Rebecca A Brachman; Niven R Narain; Michael A Kiebish; Christine A Denny
Journal:  Neuropsychopharmacology       Date:  2018-03-29       Impact factor: 7.853

2.  Altered hippocampal gene expression, glial cell population, and neuronal excitability in aminopeptidase P1 deficiency.

Authors:  Sang Ho Yoon; Young-Soo Bae; Sung Pyo Oh; Woo Seok Song; Hanna Chang; Myoung-Hwan Kim
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.